BIOADAPTIVES, INC. (BDPT) Executive Compensation
BIOADAPTIVES, INC. (BDPT) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BDPT
CIK: 1575142
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Boladale Lawal & Co ( Chartered Accountants)
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerBoladale Lawal
Audit LocationLagos, Nigeria
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-06 | 2026-10-01 | FORM 4 | 0001640334-26-001616 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0001640334-26-001451 | View SEC Doc Filr Page |
| 10-Q | 2026-08-19 | 2026-06-30 | FORM 10-Q | 0001640334-26-001393 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | FORM NT 10-Q | 0001640334-26-001379 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-01 | FORM 4 | 0001640334-26-001262 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | FORM 4 | 0001640334-26-001151 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 Filing | 0001193805-26-000750 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | FORM 10-Q | 0001640334-26-000911 | View SEC Doc Filr Page |
| 4 | 2026-05-05 | 2026-05-01 | FORM 4 | 0001640334-26-000829 | View SEC Doc Filr Page |
| 10-K | 2026-04-14 | 2025-12-31 | FORM 10-K | 0001640334-26-000718 | View SEC Doc Filr Page |
| 4 | 2026-04-03 | 2026-04-01 | FORM 4 | 0001640334-26-000637 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-31 | 2025-12-31 | FORM NT 10-K | 0001640334-26-000599 | View SEC Doc Filr Page |
| 4 | 2026-03-03 | 2026-03-01 | FORM 4 | 0001640334-26-000388 | View SEC Doc Filr Page |
| 4 | 2026-02-03 | 2026-02-01 | FORM 4 | 0001640334-26-000209 | View SEC Doc Filr Page |
| 4 | 2026-01-05 | 2026-01-01 | FORM 4 | 0001640334-26-000020 | View SEC Doc Filr Page |
| 4 | 2025-12-03 | 2025-12-01 | 4 Filing | 0001193805-25-001712 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | FORM 10-Q | 0001640334-25-002081 | View SEC Doc Filr Page |
| 4 | 2025-11-04 | 2025-11-01 | 4 Filing | 0001193805-25-001528 | View SEC Doc Filr Page |
| 4 | 2025-10-06 | 2025-10-01 | 4 Filing | 0001193805-25-001409 | View SEC Doc Filr Page |
| 4 | 2025-09-03 | 2025-09-01 | 4 Filing | 0001193805-25-001252 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | FORM 10-Q | 0001640334-25-001493 | View SEC Doc Filr Page |
| 4 | 2025-08-05 | 2025-08-01 | 4 Filing | 0001193805-25-001159 | View SEC Doc Filr Page |
| 4 | 2025-07-03 | 2025-07-01 | 4 Filing | 0001193805-25-000978 | View SEC Doc Filr Page |
| 4 | 2025-06-03 | 2025-06-01 | 4 Filing | 0001193805-25-000773 | View SEC Doc Filr Page |
| 4 | 2025-05-23 | 2025-05-01 | 4 Filing | 0001193805-25-000716 | View SEC Doc Filr Page |